Expert Review of Dermatology

Sclerotic skin disease: when smooth skin is unwelcome
pp. 487-492(6)
Authors: Tan, Audrey W; Dutz, Jan P

Siblings of melanoma patients screened
pp. 493-495(3)

Hand dermatitis: fit to work?
pp. 497-502(6)
Authors: Cox, Neil H; Gawkrodger, David J; Spiro, Jon; Beck, Mike H; English, John SC; Flower, David JC

Efalizumab for psoriasis
pp. 503-513(11)
Authors: Tsankov, Nikolai; Grozdev, Ivan

Infliximab in the treatment of psoriasis
pp. 515-526(12)
Authors: Mössner, Rotraut; Reich, Kristian

Etanercept: a tumor necrosis factor inhibitor for psoriasis and psoriatic arthritis
pp. 527-534(8)
Authors: Gratch, Noah; Weinberg, Jeffrey M; Alexis, Andrew F

Azelaic acid 15% gel for treatment of rosacea
pp. 535-545(11)
Author: Elewski, Boni E

The red skin syndromes: corticosteroid addiction and withdrawal
pp. 547-561(15)
Authors: Rapaport, Marvin J; Rapaport, Vicki

Intravenous immunoglobulin use for Stevens-Johnson syndrome in children
pp. 563-567(5)
Authors: Jacobs, Aleda A; Badgwell, Christy; Levy, Moise L; Metry, Denise W

Treatment of mycosis fungoides and Sézary syndrome: recent advances and novel therapies
pp. 569-577(9)
Author: Scarisbrick, Julia

The impact of dermoscopic-pathological correlates in the diagnosis and management of pigmented skin tumors
pp. 579-587(9)
Authors: Zalaudek, Iris; Leinweber, Bernd; Hofmann-Wellenhof, Rainer; Soyer, H Peter

Manipulating T regulatory cells in cancer immunotherapy
pp. 589-597(9)
Authors: Rüter, Jens; Barnett, Brian G; Kryczek, Ilona; Brumlik, Michael J; Daniel, Benjamin J; Coukos, George; Zou, Weiping; Curiel, Tyler J

Poly(ADP-ribose) polymerase inhibition and its potential use in malignant melanoma
pp. 599-605(7)
Author: Plummer, Ruth

Herpes zoster and postherpetic neuralgia
pp. 607-618(12)
Author: Guenther, Lyn C